Loading company…
Vivodyne develops lab-grown human tissues for drug and biologic testing.
Founded in 2020 by Andrei Georgescu and Dan Huh, Vivodyne is based in Philadelphia, US. Its platform grows living portions of human organs for drug and biologic testing. In May 2025, it raised USD 40 million in Series A funding led by Khosla Ventures, with participation from Bison Ventures, CS Venture Opportunities Fund, L.P., Kairos Ventures, MBX Capital, Helena, Lingotto Investment Management, and Fortius Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in